Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 12.585 USD -2.52%
Market Cap: 138.3m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one MED stock under the Base Case scenario is 30.135 USD. Compared to the current market price of 12.585 USD, Medifast Inc is Undervalued by 58%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MED Relative Value
Base Case
30.135 USD
Undervaluation 58%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
98
vs Industry
82
Median 3Y
0.6
Median 5Y
0.7
Industry
1
Forward
0.3
More Details
65.8
P/E
P/E
Price to Earnings
65.8
vs History
7
vs Industry
5
Median 3Y
8
Median 5Y
11.9
Industry
16.6
Forward
-12.2
More Details
5.6
P/OCF
P/OCF
Price to OCF
5.6
vs History
65
vs Industry
51
Median 3Y
5.3
Median 5Y
8.1
Industry
11.5
More Details
8.1
P/FCFE
P/FCFE
Price to FCFE
8.1
vs History
58
vs Industry
40
Median 3Y
6.2
Median 5Y
10.3
Industry
17.2
More Details
0.7
P/B
P/B
Price to Book Value
0.7
vs History
98
vs Industry
65
Median 3Y
3.9
Median 5Y
7.6
Industry
1.5
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
93
Median 3Y
0.5
Median 5Y
0.7
Industry
1.1
Forward
-0
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
91
Median 3Y
0.7
Median 5Y
1
Industry
3.8
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
70
Median 3Y
3.6
Median 5Y
5.5
Industry
9.5
Forward
-2.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
66
Median 3Y
3.9
Median 5Y
5.7
Industry
12.5
Forward
1.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
67
Median 3Y
3.3
Median 5Y
7.6
Industry
12
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
58
Median 3Y
3.6
Median 5Y
8.9
Industry
15
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
69
Median 3Y
9.4
Median 5Y
9.4
Industry
1.2
More Details

Multiples Across Competitors

MED Competitors Multiples
Medifast Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Medifast Inc
NYSE:MED
142m USD 0.2 65.8 -0.6 -1
FR
L'Oreal SA
PAR:OR
204.3B EUR 4.7 31.9 19.6 23.7
UK
Unilever PLC
LSE:ULVR
116.8B GBP 2.3 23.9 146.7 169.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.7 51.5 36.1 39.8
UK
HALEON PLC
LSE:HLN
36.6B GBP 3.3 25.4 15 16.9
DE
Beiersdorf AG
XETRA:BEI
26.9B EUR 2.7 29.6 12.5 15.3
US
Estee Lauder Companies Inc
NYSE:EL
22.1B USD 1.5 -31.5 11.6 18
JP
Kao Corp
TSE:4452
3T JPY 1.8 27.8 11.9 19.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 9 -279.9 41.3 44.3
CN
Giant Biogene Holding Co Ltd
HKEX:2367
82.9B HKD 13.9 37.4 29 29.5
IN
Dabur India Ltd
NSE:DABUR
819.3B INR 6.5 45.6 34.1 41.6
P/E Multiple
Earnings Growth PEG
US
Medifast Inc
NYSE:MED
Average P/E: 37.7
65.8
N/A N/A
FR
L'Oreal SA
PAR:OR
31.9
9%
3.5
UK
Unilever PLC
LSE:ULVR
23.9
14%
1.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
51.5
9%
5.7
UK
HALEON PLC
LSE:HLN
25.4
13%
2
DE
Beiersdorf AG
XETRA:BEI
29.6
12%
2.5
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -31.5
43%
N/A
JP
Kao Corp
TSE:4452
27.8
10%
2.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -279.9 N/A N/A
CN
G
Giant Biogene Holding Co Ltd
HKEX:2367
37.4
25%
1.5
IN
Dabur India Ltd
NSE:DABUR
45.6
9%
5.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Medifast Inc
NYSE:MED
Average EV/EBITDA: 35.8
Negative Multiple: -0.6 		N/A N/A
FR
L'Oreal SA
PAR:OR
19.6
7%
2.8
UK
Unilever PLC
LSE:ULVR
146.7
5%
29.3
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.1
10%
3.6
UK
HALEON PLC
LSE:HLN
15
5%
3
DE
Beiersdorf AG
XETRA:BEI
12.5
3%
4.2
US
Estee Lauder Companies Inc
NYSE:EL
11.6
4%
2.9
JP
Kao Corp
TSE:4452
11.9
7%
1.7
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
41.3
9%
4.6
CN
G
Giant Biogene Holding Co Ltd
HKEX:2367
29
22%
1.3
IN
Dabur India Ltd
NSE:DABUR
34.1
8%
4.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Medifast Inc
NYSE:MED
Average EV/EBIT: 41.8
Negative Multiple: -1 		N/A N/A
FR
L'Oreal SA
PAR:OR
23.7
6%
4
UK
Unilever PLC
LSE:ULVR
169.8
3%
56.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.8
9%
4.4
UK
HALEON PLC
LSE:HLN
16.9
4%
4.2
DE
Beiersdorf AG
XETRA:BEI
15.3
2%
7.6
US
Estee Lauder Companies Inc
NYSE:EL
18
5%
3.6
JP
Kao Corp
TSE:4452
19.2
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
44.3
10%
4.4
CN
G
Giant Biogene Holding Co Ltd
HKEX:2367
29.5
23%
1.3
IN
Dabur India Ltd
NSE:DABUR
41.6
7%
5.9

See Also

Summary
MED intrinsic value, competitors valuation, and company profile.
DCF Valuation
MED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MED stock valuation using valuation multiples.
Wall Street Estimates
MED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 253,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.